Seeing separations
An application of NMR/MRI technology has been developed for the characterization of flow and the detection of fast, small molecule separations within hyper-cross-linked polymer monolithic chromatography columns.
An application of NMR/MRI technology has been developed for the characterization of flow and the detection of fast, small molecule separations within hyper-cross-linked polymer monolithic chromatography columns.1 As well as demonstrating the potential for direct and remote use of magnetic resonance in studying chromatographic processes, the researchers also report it could be an important step in developing portable chromatographic devices.
According to the study, the hyper-cross-linked polymer monolithic columns exhibited excellent ruggedness, with a transit time relative standard deviation of less than 2.1%, after more than 300 column volumes were pumped through at high pressure and flow. Using magnetic resonance imaging the researchers were able to take high-resolution intensity and velocity-encoded images of mobile phase flow through the monolithic columns. The study found that the presence of a polymer monolith within the capillary disrupted the flow profile of the mobile phase, resulting in an equal distribution of analytes and mobile phase throughout the monolith in a radial direction. In-line monitoring of chromatographic separations of small molecules at high flow-rates was also shown.
1. T.Z. Teisseyre et al., Anal. Chem., published online 7 June 2011.
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
